News and Announcements
Leaf Resources Investor Update June 2015
- Published June 24, 2015 4:47PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd June, 2015
The Glycell Process
Glycerol recycling reduces cellulosic sugar cost
Leaf Resources announced today that our proprietary GlycellTM process, can now achieve a cellulosic sugar cost of $47 per tonne down from the previous $151 per tonne.
Review the full announcement here
The Glycell Process, Investor Presentation
On the 13th May 2015, Leaf Resources Managing Director, Ken Richards attended the Sydney Capital Expo and Small Cap Showcase. This exciting event produced by Wholesale Investor, Bloomberg, DLA Piper, PwC, SGX, NZTE, AusBiotech and OzForez, was held at the Shangri-La Hotel in Sydney.
The business case for the GlycellTM process was presented by Mr Richards. The full presentation can be reviewed here.
Leaf Resources up for Soffinova Partners Renewable Chemistry Start-Up Award
Leaf Resources have been added to the public vote list for the Sofinnova Partners Renewable Chemistry Start-up Award.
Vote here
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
